Shearer A Eliot, Eppsteiner Robert W, Booth Kevin T, Ephraim Sean S, Gurrola José, Simpson Allen, Black-Ziegelbein E Ann, Joshi Swati, Ravi Harini, Giuffre Angelica C, Happe Scott, Hildebrand Michael S, Azaiez Hela, Bayazit Yildirim A, Erdal Mehmet Emin, Lopez-Escamez Jose A, Gazquez Irene, Tamayo Marta L, Gelvez Nancy Y, Leal Greizy Lopez, Jalas Chaim, Ekstein Josef, Yang Tao, Usami Shin-ichi, Kahrizi Kimia, Bazazzadegan Niloofar, Najmabadi Hossein, Scheetz Todd E, Braun Terry A, Casavant Thomas L, LeProust Emily M, Smith Richard J H
Molecular Otolaryngology & Renal Research Labs, Department of Otolaryngology-Head and Neck Surgery, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA.
Department of Biomedical Engineering, University of Iowa, Iowa City, IA 52242, USA.
Am J Hum Genet. 2014 Oct 2;95(4):445-53. doi: 10.1016/j.ajhg.2014.09.001. Epub 2014 Sep 25.
Ethnic-specific differences in minor allele frequency impact variant categorization for genetic screening of nonsyndromic hearing loss (NSHL) and other genetic disorders. We sought to evaluate all previously reported pathogenic NSHL variants in the context of a large number of controls from ethnically distinct populations sequenced with orthogonal massively parallel sequencing methods. We used HGMD, ClinVar, and dbSNP to generate a comprehensive list of reported pathogenic NSHL variants and re-evaluated these variants in the context of 8,595 individuals from 12 populations and 6 ethnically distinct major human evolutionary phylogenetic groups from three sources (Exome Variant Server, 1000 Genomes project, and a control set of individuals created for this study, the OtoDB). Of the 2,197 reported pathogenic deafness variants, 325 (14.8%) were present in at least one of the 8,595 controls, indicating a minor allele frequency (MAF) > 0.00006. MAFs ranged as high as 0.72, a level incompatible with pathogenicity for a fully penetrant disease like NSHL. Based on these data, we established MAF thresholds of 0.005 for autosomal-recessive variants (excluding specific variants in GJB2) and 0.0005 for autosomal-dominant variants. Using these thresholds, we recategorized 93 (4.2%) of reported pathogenic variants as benign. Our data show that evaluation of reported pathogenic deafness variants using variant MAFs from multiple distinct ethnicities and sequenced by orthogonal methods provides a powerful filter for determining pathogenicity. The proposed MAF thresholds will facilitate clinical interpretation of variants identified in genetic testing for NSHL. All data are publicly available to facilitate interpretation of genetic variants causing deafness.
在非综合征性听力损失(NSHL)和其他遗传疾病的基因筛查中,次要等位基因频率的种族特异性差异会影响变异分类。我们试图在大量来自不同种族人群的对照样本背景下,使用正交大规模平行测序方法对所有先前报道的致病性NSHL变异进行评估。我们利用人类基因突变数据库(HGMD)、临床变异数据库(ClinVar)和单核苷酸多态性数据库(dbSNP)生成了一份已报道的致病性NSHL变异的综合列表,并在来自12个群体的8595名个体以及来自三个来源(外显子变异服务器、千人基因组计划以及为本研究创建的个体对照组OtoDB)的6个不同种族的主要人类进化系统发育群体背景下,对这些变异进行了重新评估。在2197个已报道的致病性耳聋变异中,325个(14.8%)在8595名对照样本中的至少一个中出现,表明次要等位基因频率(MAF)>0.00006。MAF高达0.72,这一水平与NSHL这种完全显性疾病的致病性不相符。基于这些数据,我们确定了常染色体隐性变异(不包括GJB2中的特定变异)的MAF阈值为0.005,常染色体显性变异的MAF阈值为0.0005。使用这些阈值,我们将93个(4.2%)已报道的致病性变异重新分类为良性。我们的数据表明,使用来自多个不同种族且通过正交方法测序的变异MAF来评估已报道的致病性耳聋变异,为确定致病性提供了一个强大的筛选工具。所提出的MAF阈值将有助于对NSHL基因检测中鉴定出的变异进行临床解读。所有数据均可公开获取,以方便对导致耳聋的基因变异进行解读。